Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction

Table 1 Characteristics of the recruited patients

Characteristic	Surviving	Dead
Gender
Male	148 (78.3)	134 (80.7)
Female	41 (21.7)	32 (19.3)
Age (yr)	65.00 (60.00-71.00)	63.00 (59.00-69.25)
Tumor size	5.00 (4.00-7.00)	4.00 (2.50-5.50)
TNM stage
I-II	49 (25.9)	105 (63.3)
III	140 (74.1)	61 (36.7)
Differentiation grade
Low	59 (31.2)	70 (42.2)
High	130 (68.8)	96 (57.8)
BMI (kg/m2)	21.23 (19.88-23.85)	22.96 (20.96-25.00)
Tumor location
Siewert II	104 (55.0)	98 (59.0)
Siewert III	85 (45.0)	68 (41.0)
NLR	2.37 (1.61-3.62)	2.20 (1.55-2.86)
PLR	122.75 (87.98-182.94)	108.03 (81.43-152.54)
CEA	3.60 (1.95-9.30)	2.20 (1.44-6.85)
CA199	10.34 (5.64-20.26)	9.88 (5.75-16.88)
PNI	48.80 (45.30-53.15)	50.35 (47.20-53.45)
Albumin	41.60 (38.40-44.80)	42.40 (39.48-44.30)
Prealbumin	187.00 (153.50-234.00)	239.50 (201.75-264.25)
Neutrophil count	3.41 (2.72-4.53)	3.26 (2.38-4.48)
Platelet count	188.00 (143.00-235.50)	176.00 (145.00-219.50)
Lymphocyte count	1.43 (1.10-1.82)	1.63 (1.26-1.97)

Categorical values are expressed as number (percentage), and continuous variable are expressed as median (25^th percentile and 75^th percentile). NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; BMI: Body mass index; PNI: Prognostic nutritional index; CEA: Carcinoembryonic antigen.